NCT03622502View on ClinicalTrials.gov

The Effect of Dexmedetomidine for Emergence Cough

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 16, 2018

Primary Completion Date

March 22, 2019

Study Completion Date

March 27, 2019

Conditions
Cough
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine 0.5mcg/kg was infused over 10 min before end of the surgery

DRUG

Remifentanil

Remifentanil was maintained at predetermined effect-site concentration during the periextubation period (initial concentration: 2.0 ng/ml)

DRUG

Normal saline

Normal saline was infused over 10 min before end of the surgery

Trial Locations (1)

443-721

Ajou University Hospital, Suwon

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT03622502 - The Effect of Dexmedetomidine for Emergence Cough | Biotech Hunter | Biotech Hunter